Skip to main content

The Globe and Mail

Bayer to buy software developer Radimetrics

An employee of German chemical and pharmaceutical maker Bayer controls processing equipment at the pill plant in Bitterfeld, eastern Germany, in this file picture.


Drug multinational Bayer AG says it has struck a deal to buy Canadian healthcare software developer Radimetrics Inc.

Subsidiary Bayer HealthCare said Monday the principals of privately held Radimetrics have agreed to sell of their shares in the company.

Radimetrics' key product is eXposure, software that accurately measures a patient's radiation dose exposure over the course of multiple imaging procedures or scans.

Story continues below advertisement

Bayer HealthCare said eXposure also serves as a quality control and improvement platform.

Financial details of the agreement were not disclosed.

"This is a strategic acquisition as Bayer moves its Radiology & Interventional business forward to be the end-to-end provider of products, solutions and service for the radiology customer," Alan Main, head of Bayer HealthCare's medical care unit, said in a news release.

Radimetrics staff in Toronto and Scotland will be folded into Bayer, expanding Bayer's existing informatics group.

Radimetrics was founded in 2009.

Mr. Main said Bayer HealthCare's Radiology & Interventional group is poised as a market leader to help boost sales of eXposure.

Radimetrics president and founder Gregory Couch said the deal is "a new chapter in a great alliance which began earlier this year."

Story continues below advertisement

Report an error Editorial code of conduct Licensing Options
As of December 20, 2017, we have temporarily removed commenting from our articles. We hope to have this resolved by the end of January 2018. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to If you want to write a letter to the editor, please forward to